USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS
The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated...
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
20.02.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent. |
|---|---|
| AbstractList | The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent. |
| Author | LARRICK, James W SCHNIPPER, Edward F ZHANG, Xiaoming PERLMAN, Andrew J |
| Author_xml | – fullname: LARRICK, James W – fullname: PERLMAN, Andrew J – fullname: SCHNIPPER, Edward F – fullname: ZHANG, Xiaoming |
| BookMark | eNrjYmDJy89L5WQwDw12VfB3U_Dz1jVUCHJ1dg0I8Q9ScPQLcXT39_MMDlEIdg3y8Q_wDAEKKXj6KQQEhQZ5hoQG8zCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwMjAwNTEzMDY0dDY-JUAQDmiSrr |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US2020054603A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2020054603A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 15:43:39 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2020054603A13 |
| Notes | Application Number: US201916364075 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200220&DB=EPODOC&CC=US&NR=2020054603A1 |
| ParticipantIDs | epo_espacenet_US2020054603A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20200220 |
| PublicationDateYYYYMMDD | 2020-02-20 |
| PublicationDate_xml | – month: 02 year: 2020 text: 20200220 day: 20 |
| PublicationDecade | 2020 |
| PublicationYear | 2020 |
| RelatedCompanies | Menlo Therapeutics Inc |
| RelatedCompanies_xml | – name: Menlo Therapeutics Inc |
| Score | 3.2583525 |
| Snippet | The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200220&DB=EPODOC&locale=&CC=US&NR=2020054603A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkDpW7Ffa7eHIVs_XJW1pU1lbyPpBwjSDVfx3_caN93T3pI7OC4Hl7tL8rsAPLCBUao5U9CRMixQ9ILL3GK5jLGuUJk2GHABj54F5jQ1Xub9eQs-tlgY0Sf0WzRHRI_K0N9rsV-v_g-xHPG2cv3I35G0fPLoyJE21XHz4kBTJGcycqPQCW3JtkdpIgXxL69vmIo-xlrpoEmkm0777tukwaWsdoOKdwqHEcqr6jNoFVUHju3t32sdOJptrrxxuPG-9TlYaeKS0CPBq6yS2LXdiIYxGQd0_BwGfkJJgqlpGPkUScQPSBSnsU_T5ALuPZfaUxk1WPwteJEmu-rql9CullVxBQSNmptapg65phusHLKcW5rOrKFVlmbBlC709km63s--gZNmKgDbSg_a9edXcYsht-Z3wlI_c15_bA |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQGlb8V-rd0ehmz9cHVbW9pU9jaStQVBuuEq_vve4qZ72lu4g-NycLn8kvwuAI-sYxRqxhRMpDkCFD3nMrdYJmOty1WmdTpc0KMngTlMjddpe1qDjy0XRvQJ_RbNETGj5pjvlVivl_-HWI54W7l64u8oWjx7tOdIG3S8fnGgKZIz6LlR6IS2ZNu9NJGC-FfXNkxF7yNWOrAQFAqw9DZY81KWu0XFO4HDCO2V1SnU8rIJDXv791oTjiabK28cbrJvdQZWmrgk9EgwklUSu7Yb0TAm_YD2X8LATyhJcGsaRj5FEfEDEsVp7NM0OYcHz6X2UEYPZn8TnqXJrrv6BdTLRZlfAsGgZqY2V7tc0w1WdFnGLU1nVtcqCjNnyhW09lm63q--h8aQTsazsR-MbuB4rRLkbaUF9erzK7_F8lvxOxG1H44EglY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+NK-1+RECEPTOR+ANTAGONIST+SERLOPITANT+IN+PRURITUS&rft.inventor=LARRICK%2C+James+W&rft.inventor=PERLMAN%2C+Andrew+J&rft.inventor=SCHNIPPER%2C+Edward+F&rft.inventor=ZHANG%2C+Xiaoming&rft.date=2020-02-20&rft.externalDBID=A1&rft.externalDocID=US2020054603A1 |